Oestrogen receptor status of breast carcinoma: Allred/H score conversion table-Reference-Cited by-同舟云学术

Oestrogen receptor status of breast carcinoma: Allred/H score conversion table

Published:2008-09 Issue:3 Volume:53 Page:346-347
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Shousha S

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2008.03075.x/fullpdf

Reference4 articles.

1. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies;McCarty;Arch. Pathol. Lab. Med.,1985

2. Immunohistochemical demonstration of oestrogen and progesterone receptors in paraffin sections of breast carcinoma;Shousha;Curr. Diag. Pathol.,1997

3. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J. Clin. Oncol.,1999

4. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol;Leake;J. Clin. Pathol.,2000

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center;The Breast;2024-06

2. Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer;The Journal of Pathology;2023-08-09

3. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5%;Scientific Reports;2023-08-09

4. Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer;Breast Cancer Research and Treatment;2023-03-03

5. Concordancia entre la prueba de puntuación de recurrencia de 21 genes y modelos clínico-patológicos predictivos en pacientes con cáncer de mama temprano en un centro oncológico en Colombia;Gaceta Médica de México;2023-02-09